| Literature DB >> 31460040 |
Maria Carmen S Tan1, Mary Stephanie S Carranza1, Virgilio C Linis1, Raymond S Malabed1,2, Glenn G Oyong1.
Abstract
The objective of this research was to find the possible pharmacognosy of the bark of the Philippine Alstonia macrophylla Wall. ex G.Don (AM). Gas chromatographic-mass spectral (GC-EI-MS) characterization and energy dispersive X-ray spectroscopy (EDX) were performed to detect the bioactive constituents. EDX analysis of AM bark displayed a high content of potassium (3.26%) and calcium (2.96%). Eight constituents were detected in AM crude dichloromethane (DCM) extracts, which consisted of a long-chain unsaturated fatty acid (17:0) and fatty acid esters such as ethyl hexadecanoate and methyl hexadecanoate. Extraction of AM bark using methanol and dimethyl sulfoxide (MeOH/DMSO) solvents resulted in the identification of 17 constituents, principally alkaloids (alstonerine, 34.38%; strictamin, 5.23%; rauvomitin, 4.29%; and brucine, 3.66%) and triterpenoids (γ-sitosterol, 3.85%; lupeol, 3.00%; 24-methylenecycloartanol, 2.81%; campesterol, 2.71%; β-amyrin, 2.30%; and stigmasterol, 2.13%). MeOH/DMSO samples of AM were used in the selected bioassays. The samples exhibited efficient free radical scavenging activity (IC50 = 0.71 mg/mL) and were noncytotoxic to normal HDFn (IC50 > 100 μg/mL) and neoplastic THP-1 cell lines (IC50 = 67.22 μg/mL) while highly degenerative to MCF-7 (IC50 = 6.34 μg/mL), H69PR (IC50 = 7.05 μg/mL), and HT-29 (IC50 = 9.10 μg/mL). Most interestingly, the AM samples inhibited the northern Philippine Cobra's (Naja philippinensis Taylor) venom (IC50 = 297.27 ± 9.33 μg/mL) through a secretory phospholipase A2 assay.Entities:
Year: 2019 PMID: 31460040 PMCID: PMC6648722 DOI: 10.1021/acsomega.9b00082
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Volatile Constituents of DCM Extracts of AM
| compound | RT (min) | RI | % peak area | functionality |
|---|---|---|---|---|
| 2-ethenyl-2-butenal | 8.07 | 890 | 6.17 | aldehyde |
| 3-ethylpyridine | 11.38 | 956 | 1.21 | diverse functional group |
| nonanoic acid | 31.72 | 1277 | 0.92 | carboxylic acid |
| cyclohexylbenzene | 33.81 | 1309 | 4.96 | hydrocarbon |
| 3-hydroxy-4-methoxybenzyl alcohol | 42.38 | 1445 | 8.41 | alcohol |
| hexadecanonic acid methyl ester | 68.37 | 1927 | 10.46 | ester |
| hexadecanoic acid ethyl ester | 71.40 | 1990 | 12.21 | ester |
| heptadecanoic acid | 74.80 | 2065 | 16.61 | carboxylic acid |
Retention index (HP-5 ms column).
Figure 1Total ion GC–MS chromatogram of (a) DCM and (b) MeOH/DMSO extract of AM with n-alkanes.
Volatile Constituents of MeOH:DMSO Extracts of AM
| compound | RT (min) | RI | % peak area | functionality |
|---|---|---|---|---|
| 2,5-dimethyl-4-hydroxy-3(2 | 7.20 | 1026 | 1.16 | trihydroxybenzene |
| 2-methoxy-4-vinylphenol | 19.96 | 1355 | 5.37 | diterpenoid |
| 2,6-dimethoxyphenol | 22.13 | 1375 | 1.83 | diverse functional group |
| 2,6-dimethoxy-4-(2-propenyl)-phenol | 45.43 | 1660 | 3.69 | diverse functional group |
| 3,5-dimethoxy-4-hydroxyphenylacetic acid | 49.60 | 1690 | 1.66 | phenolic acid |
| strictamin | 77.42 | 2519 | 5.23 | alkaloid |
| rauvomitin | 84.82 | 2522 | 4.29 | alkaloid |
| alstonerine | 86.66 | 2544 | 34.38 | alkaloid |
| brucine | 86.85 | 2545 | 3.66 | alkaloid |
| burnamicine | 87.94 | 2561 | 1.71 | alkaloid |
| campesterol | 93.35 | 2643 | 2.71 | triterpenoid |
| stigmasterol | 94.44 | 2663 | 2.13 | triterpenoid |
| γ-sitosterol | 96.48 | 2701 | 3.85 | triterpenoid |
| β-amyrin | 97.27 | 2716 | 2.30 | triterpenoid |
| lupeol | 98.43 | 2738 | 3.00 | triterpenoid |
| 24-methylenecycloartanol | 101.84 | 2802 | 2.81 | triterpenoid |
Retention index (HP-5 ms column).
Figure 2EDX image (top) and X-ray energy spectrum (bottom) of AM bark.
Figure 3Free radical scavenging analyses of AM.
Figure 4Cytotoxic activities of AM, Zeocin, and DMSO on the cytotoxicity index (CI%) of immortalized cell lines (dose–response curves with data points as mean ± SEM). GraphPad Prism 7.01 (GraphPad Software, Inc., USA) was employed for extra sum-of-squares F test calculations to (A) appraise the implication of the best-fit-parameter (half maximal inhibitory concentration) between selected trials and to (B) assess the variances amid the dose–response curve fits. MCF-7 F (Dfn, DFd) = (A) F (2, 48) = 3192, p < 0.0001 and (B) F (2, 21) = 34.37, p < 0.0001; H69PR (A) F (2, 48) = 5205, p < 0.0001and (B) F (2, 21) = 29.45, p < 0.0001; HT-29 (A) F (2, 46) = 4892, p < 0.0001 and (B) F (2, 21) = 18.81, p < 0.0001; THP-1 (A) F (2, 48) = 3511, p < 0.0001 and (B) F (2, 21) = 12.41, p = 0.0003; HDFn (A) F (2, 48) = 1577, p < 0.0001 and (B) F (2, 21) = 27.70, p < 0.0001.
Figure 5Cytotoxic activities of AM based on the CI% of the immortalized cell lines. Graphs show the result of AM on individual cell lines. Dose–response curves were formed from data points as mean ± SEM. The GraphPad Prism 7.01 software was applied to perform the extra sum-of-squares F test to (A) gauge the implication of the best-fit-parameter of IC50 values between separate treatments and to (B) ascertain the variances amid the dose–response curve congruency. AM, (A) F (4, 80) = 445.2, p < 0.0001 (B) F (4, 35) = 4.176, p = 0.0072.
Cytotoxic Activities (IC50) of the AM Crude Extract and Zeocin against Cell Lines
| IC50 | |||||
|---|---|---|---|---|---|
| sample | MCF-7 | H69PR | HT-29 | THP-1 | HDFn |
| AM | 6.34 | 7.05 | 9.10 | 67.22 | >100 |
| Zeocin | 3.37 | 3.83 | 3.78 | 3.59 | 4.08 |
IC50 data were deduced from dose–response graphs extrapolated from nonlinear regression analysis by means of GraphPad Prism 7.01 The unpaired two-tailed t test was the treatment employed for each cell line to evaluate the significant variances among the data groups. The statistical data were as follows: MCF-7, t (14) = 0.7047, p = 0.4925; H69PR, t (14) = 0.7285, p = 0.4783; HT-29, t (14) = 1.056, p = 0.3090; THP-1, t (14) = 2.798, p = 0.0142; HDFn, t (14) = 3.761, p = 0.0021.
Figure 6Linear regression analysis of the variation in absorbance (ΔA414) as the slope (top) and inhibitory outcome of AM in contradiction of sPLA2 activity from NPV (bottom).